Pharmaceutical companies hiked the price of 775 drugs this year so far, including Ozempic and Mounjaro — exceeding the rate of inflation::Meanwhile, Senate to consider subpoenas to force pharma CEOs testify on prices.
Pharmaceutical companies hiked the price of 775 drugs this year so far, including Ozempic and Mounjaro — exceeding the rate of inflation::Meanwhile, Senate to consider subpoenas to force pharma CEOs testify on prices.
So how much of this is because pharma companies have to cap prices of some drugs because of the Inflation Reduction Act, but they still want to keep the revenue looking good for shareholders?
Probably none, because it implies prices wouldn’t have risen this year beyond inflation without the IRA.